Orchard Therapeutics plc Overview

Orchard Therapeutics plc Total Revenue

Revenue analysis for ORTX.

Quarterly Revenue

$6.30M

↑ 9.09% YoY

As of Sep 2023

Annual Revenue (TTM)

$21.84M

↑ 35.21% YoY

Trailing 12 months ending Sep 2023

Average Revenue (Comparison Companies)

Total Revenue History

Total Revenue Comparison

Annual Revenue Growth Rate (%)

Annual Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin